Get started
Emergent BioSolutions Inc. 3.875% 15-AUG-2028Emergent BioSolutions Inc. 3.875% 15-AUG-2028Emergent BioSolutions Inc. 3.875% 15-AUG-2028

Emergent BioSolutions Inc. 3.875% 15-AUG-2028

No trades
See on Supercharts
Overview
Analysis

EBS5025998 chart


Full chart

Key terms


Outstanding amount
‪450.00 M‬ USD
Face value
1,000.00 USD
Minimum denomination
2,000.00 USD
Coupon
3.88% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
—
Maturity date
Aug 15, 2028
Term to maturity
3 years

About Emergent BioSolutions Inc. 3.875% 15-AUG-2028


Issuer
Emergent BioSolutions, Inc.
Sector
Health Technology
Home page
emergentbiosolutions.com
Issue date
Aug 7, 2020
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

EBS5025998 analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.